Then, a novel five lipid metabolism genes signature (AKR1B1, MTF1, PLA2R1, GGPS1, and ETNPPL) was constructed to predict clinical outcomes in gastric cancer, which are listed in Table 1. This evidence concerns the gene PLA2R1 and gastric cancer.